Keith Westby - 15 Feb 2022 Form 4 Insider Report for IVERIC bio, Inc.

Role: SVP & COO
Signature: /s/ Todd Anderman, as attorney-in-fact for Keith Westby
Issuer symbol: N/A
Transactions as of: 15 Feb 2022
Net transactions value: -$151,634
Form type: 4
Filing time: 17 Feb 2022, 15:03:27 UTC
Previous filing: 08 Feb 2022
Next filing: 02 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISEE	Common Stock	Sale	$151,634	-10,000	-8.5%	$15.16	108,280	15 Feb 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2021.
F2	The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $15.0000 to $15.3200 per share on February 15, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.

Content

The sale reported on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2021.

The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $15.0000 to $15.3200 per share on February 15, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.